Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Type I interferons play a key role in the development of various skin diseases.

Trichoscopy can help identify systemic diseases, not just hair and scalp issues.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

Tetracycline successfully treated a Labrador's skin calcification and hair loss.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Targeted cancer therapies often cause serious skin problems that need careful management.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.